Article
T cell-mediated protection against lethal SARS-CoV-2 challenge by a synthetic long peptide vaccine targeting conserved CD4+ and CD8+ T cell epitopes
2026-06-24
Abstract excerpt
<title>Abstract</title> <p> <bold>Background</bold> The majority of approved SARS-CoV-2 prophylactic vaccines are based on mRNA or viral vector platforms and act through the induction of neutralizing IgG antibodies against conformational B cell epitopes of the viral Spike (S) protein, as well as the induction of virus-specific T cell responses. <bold>Methods</bold> In this study, we designed a synthetic long...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 80d15ffa-4d50-5e01-afe8-8bb474c64c82
- DOI
- 10.21203/rs.3.rs-10017848/v1
